Literature DB >> 910722

Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.

D P Zipes, W E Gaum, P R Foster, K M Rosen, D Wu, F Amat-Y-Leon, R J Noble.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910722     DOI: 10.1016/0002-9149(77)90075-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 2.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

3.  Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.

Authors:  Y Ohmoto-Sekine; H Uemura; M Tamagawa; H Nakaya
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Electrophysiologic actions of aprindine in rabbit atrioventricular node.

Authors:  H Tanaka; M Nishimura; N Homma; Y Habuchi; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

5.  Inhibitory effect of aprindine on Na+/Ca2+ exchange current in guinea-pig cardiac ventricular myocytes.

Authors:  Yasuhide Watanabe; Takahiro Iwamoto; Munekazu Shigekawa; Junko Kimura
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 6.  Reliability of antiarrhythmic drug plasma concentration monitoring.

Authors:  F Follath; U Ganzinger; E Schuetz
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.